SCHEMBL22734404

SCHEMBL22734404

CC(C)(C)OC(=O)NC(CO)Cc1ccc(OC(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.53
ABCB1 P08183 1/20 0.50
ACACB O00763 2/20 0.49
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
APP P05067 3/20 0.44
CTSS P25774 6/20 0.44
CTSK P43235 5/20 0.44
PCNA P12004 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13919604 1.00 ATM (0.53) ATMABCB1ACACBITGB3ITGA2B
SCHEMBL22774852 1.00 ATM (0.53) ATMABCB1ACACBITGB3ITGA2B
SCHEMBL27848339 0.95 ABCB1 (0.52) ATMABCB1ACACBITGB3ITGA2B
SCHEMBL20661670 0.89 ATM (0.53) ATMACACBITGB3ITGA2BAPP
SCHEMBL4363556 0.89 ATM (0.53) ATMACACBITGB3ITGA2BAPP
SCHEMBL24569507 0.87 ATM (0.54) ATMABCB1ACACBITGB3ITGA2B
SCHEMBL21852417 0.87 ACACB (0.51) ATMACACBITGB3ITGA2BHDAC8
SCHEMBL7465898 0.87 ATM (0.51) ATMITGB3ITGA2BAPPCTSS
SCHEMBL7465905 0.87 ATM (0.51) ATMITGB3ITGA2BAPPCTSS
SCHEMBL21852432 0.87 ACACB (0.51) ATMACACBITGB3ITGA2BHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3759107-B1 SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH AN N-1 BRANCHED GROUP SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-12-04 EP disclosed
US-11370788-B2 Substituted imidazo[4,5-c]quinoline compounds with an N-1 branched group 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-06-28 US disclosed
US-20220194935-A1 PHENETHYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH AN N-1 BRANCHED GROUP SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-06-23 US disclosed
CN-113906027-A Phenethyl substituted imidazo [4,5-c ] quinoline compounds with N-1 branched groups 3M创新有限公司 2022-01-07 CN disclosed
US-20200385379-A1 SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH AN N-1 BRANCHED GROUP SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2020-12-10 US disclosed
CN-101921268-B 5-thiazole amide compound and biological applications 中山大学肿瘤防治中心 2016-08-03 CN disclosed
CN-101921268-A 5-thiazole amide compound and biology application thereof UNIV SUN YAT SEN CANCER CT 2010-12-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11370788-B2 Substituted imidazo[4,5-c]quinoline compounds with an N-1 branched group IFNG, IFNAR1, IRF3 ATM 3385/4885ABCB1 2002/4885ACACB 2295/4885
US-20220194935-A1 PHENETHYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH AN N-1 BRANCHED GROUP IFNG, IFNAR1, IRF3 ATM 3900/4885ABCB1 2217/4885ACACB 2152/4885
US-20200385379-A1 SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH AN N-1 BRANCHED GROUP IFNG, IFNAR1, IRF3 ATM 3498/4885ABCB1 2701/4885ACACB 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.